Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

3.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.8K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

9.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

7.1K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.1K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

7.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Method to Guide Pressure Selection for Programmable Pressure Valves after Ventriculoperitoneal Shunt Surgery.

Asian journal of neurosurgery·2026
Same author

Apelin-13 enhances neurofunctional recovery and suppresses neuroinflammation via the SIRT1/NF-κB axis in ischemic stroke.

Cellular immunology·2025
Same author

STING Activation in Various Cell Types in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

What is holding back preclinical GPR119 agonists from their potential as the therapeutics of type 2 diabetes?

Expert opinion on therapeutic targets·2024
Same author

Hepatic transcriptome discloses the potential targets of Xuefu Zhuyu Decoction ameliorating non-alcoholic fatty liver disease induced by high-fat diet.

Journal of traditional and complementary medicine·2024
Same author

The Antiobesity Effects and Potential Mechanisms of <i>Theaflavins</i>.

Journal of medicinal food·2023

Related Experiment Video

Updated: Feb 19, 2026

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
08:12

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins

Published on: January 8, 2018

11.9K

IRS posttranslational modifications in regulating insulin signaling.

Jinghua Peng1,2, Ling He3

  • 1Division of Metabolism and EndocrinologyDepartments of Pediatrics and Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Journal of Molecular Endocrinology
|November 3, 2017
PubMed
Summary

Elevated endotoxin in obese mice induces P300 acetyltransferase, impairing insulin signaling by modifying IRS1/2. Targeting P300 may treat type 2 diabetes.

Keywords:
diabetes IIinsulin actioninsulin receptorinsulin signalingliver

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

10.9K
Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay
08:34

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

711

Related Experiment Videos

Last Updated: Feb 19, 2026

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
08:12

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins

Published on: January 8, 2018

11.9K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

10.9K
Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay
08:34

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

711

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Background:

  • Insulin resistance is central to type 2 diabetes, but its mechanisms are unclear.
  • Posttranslational modifications of insulin receptor substrate (IRS) are crucial for insulin signaling.
  • Sirtuin 1 enhances insulin sensitivity, but its opposing acetyltransferase remains unidentified.

Purpose of the Study:

  • To identify the acetyltransferase involved in insulin resistance.
  • To investigate the role of endotoxin (LPS) and the IRE1-XBP1s pathway in this process.
  • To explore P300 as a potential therapeutic target for diabetes.

Main Methods:

  • Utilized obese mouse models with elevated liver endotoxin (LPS) levels.
  • Investigated the IRE1-XBP1s pathway activation.
  • Assessed the acetylation of IRS1 and IRS2 by P300.
  • Analyzed insulin signaling pathway function.

Main Results:

  • Elevated LPS levels in obese mice induced P300 expression via the IRE1-XBP1s pathway.
  • Induced P300 acetylated IRS1 and IRS2, impairing insulin signaling.
  • P300 activity was directly linked to insulin resistance in this model.

Conclusions:

  • The P300 acetyltransferase, induced by LPS through IRE1-XBP1s, contributes to insulin resistance.
  • P300-mediated acetylation of IRS proteins is a key mechanism in diabetes development.
  • Inhibiting P300 activity presents a potential therapeutic strategy for type 2 diabetes.